Polaryx Therapeutics PLYX
NASDAQ PLYX
$1.95 +0.08 (+4.28%)
At close: Nov 11, 2026 · 4:00 PM EST

Polaryx Therapeutics (PLYX) Selling, General & Administrative (2025 - 2026)

Updated

Polaryx Therapeutics' Selling, General & Administrative was $661,000 in Q2 2026, up 62.0% from $408,000 a year earlier but down 48.3% from the prior quarter.

Analysis

Polaryx Therapeutics (PLYX) Selling, General & Administrative (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Polaryx Therapeutics' Selling, General & Administrative was $2.68 million through Jun 30, 2026; for FY2025, it was $1.56 million, up 0.9% from FY2024.

  • In earlier years, Selling, General & Administrative was $1.54 million in FY2024.
  • Quarterly Selling, General & Administrative has moved between $336,000 (Q1 2025) and $1.28 million (Q1 2026) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.13 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 6.29 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.09 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.89 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 5.11 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.68 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.64 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 3.28 Bn
10 Polaryx Therapeutics 93.21 Mn 68.83 Mn - 661,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 661,000.00
Mar 31, 2026 1.28 Mn
Jun 30, 2025 408,000.00
Mar 31, 2025 336,000.00
API Access

Polaryx Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=PLYX&period=max&api_key=YOUR_API_KEY